EUVIMED · CrossrefJournal
Leukemia Research
ISSN 0145-2126 · Elsevier BV
Latest articles
Integrating a clinical database and institutional biobank to map the epidemiological landscape and survival outcomes of lymphoma in Saudi Arabia
Longitudinal changes in diamine oxidase activity and gut microbiota in hematopoietic stem cell transplantation recipients
Cyclophosphamide maintenance in multiple myeloma without transplantation: A real-world study
SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics
Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study
Risk of subsequent primary acute myeloid leukemia after breast cancer: A population-based analysis of 608,268 women in the SEER Program
CDC20 and CEP55: essential players for pathogenesis of chromosomal abnormalities in MDS?
Multiple and central nervous system extranodal involvement predict poor prognosis in R/R DLBCL following CD19 CAR-T therapy
Clinical characteristics and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a final report of CML Cooperative Study Group
Clinicopathologic spectrum of PHF6 mutation across a heterogeneous cohort of myeloid malignancies: A single institution experience
Ferritin provides prognostic information beyond the iCPSS and BLAST-Mol in patients with CMML
Idarubicin Synergistically Enhances NK Cell-Mediated Cytotoxicity by Upregulating the AML Cell Surface Ligand ULBP2
Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study
Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why?
Efficacy and safety of BCMA-directed bispecific antibodies in relapsed and/or refractory systemic AL amyloidosis: A systematic review and meta-analysis
CPX-351 versus venetoclax plus hypomethylating agents for newly diagnosed acute myeloid leukemia: A systematic review and meta-analysis
Rusfertide rapidly decreases hematocrit in patients with suboptimally controlled polycythemia vera
Low-dose ropeginterferon alfa-2b and peginterferon alfa-2a have comparable efficacy and tolerability in polycythemia vera
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study
Deep learning-based morphological assessment of myelodysplastic syndrome on bone marrow smears
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study
Identification of ZNF384 as a regulator of epigenome in leukemia
Targeted antibody therapy as a treatment strategy for aggressive adult T-cell leukemia/lymphoma
RCHOP plus BTK inhibitor improves clinical outcomes in double expressor diffuse large B-cell lymphoma, unlike RCHOP plus lenalidomide
Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study
Recent progress in pathological understanding of adult T-cell leukemia/lymphoma in the new classification era
Clinical relevance of long non-coding RNA in acute myeloid leukemia: A systematic review with meta-analysis
Therapeutic advances for the management of adult T cell leukemia: Where do we stand?
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure
Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population
Volumes
2026 · 1022025 · 3912024 · 1162023 · 3452022 · 2682021 · 2942020 · 1332019 · 3942018 · 2302017 · 5062016 · 2322015 · 5572014 · 4312013 · 6902012 · 3772011 · 8102010 · 4442009 · 6712008 · 3532007 · 7712006 · 3282005 · 4262004 · 2432003 · 1842002 · 1842001 · 1662000 · 1451999 · 1951998 · 1711997 · 3731996 · 1441995 · 1481994 · 2551993 · 1681992 · 1851991 · 3101990 · 1591989 · 1601988 · 1481987 · 172
EUVIMED